Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2001
05/01/2001US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
05/01/2001US6225324 Antidepressant heterocyclic compounds
05/01/2001US6225313 Substituted 2-phenyl-3(2H)-pyridazinones
05/01/2001US6225312 Piperazine and piperidine compounds
05/01/2001US6225309 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
05/01/2001US6225308 Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy
05/01/2001US6224864 Culture product of streptomyces
05/01/2001CA2268703C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity
04/2001
04/26/2001WO2001029245A2 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS
04/26/2001WO2001029031A1 Process for the preparation of paroxetine
04/26/2001WO2001029030A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders
04/26/2001WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators
04/26/2001WO2001029025A2 Tyrosine kinase inhibitors
04/26/2001WO2001029021A1 Neuraminidase inhibitors
04/26/2001WO2001029012A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
04/26/2001WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
04/26/2001WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001WO2001028979A2 Inhibitors of neuraminidases
04/26/2001WO2001028561A1 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
04/26/2001WO2001002357A3 Process for the synthesis of 4-(4'-fluorophenyl)-piperidines
04/26/2001WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents
04/26/2001WO2000055125A3 N-cyanomethyl amides as protease inhibitors
04/26/2001DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones
04/26/2001CA2388859A1 Inhibitors of neuraminidases
04/26/2001CA2387972A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders
04/26/2001CA2386487A1 Enzymatic process for the resolution of enantiomeric mixtures of .beta.-lactams
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators
04/25/2001EP0994872B1 4-phenylpiperidine compounds
04/25/2001CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/25/2001CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists
04/25/2001CN1064965C Novel sulfonamides compound and its use as medicine
04/25/2001CN1064964C Novel benzobiukyl, preparation of same and parmaceutical composition of same
04/24/2001US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors
04/24/2001US6222039 Reacting lactone compound containing nitrogen heterocycle with cyclic amine; oxidizing to form carboxylic acid group; introducing hydroxylamine group at hydroxyl of carboxylic acid group
04/24/2001US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde
04/24/2001US6221937 Mixtures; photostability, heat and oxidation resistance; for polymers
04/24/2001US6221884 Carboxamides useful as 5-HT1F agonists
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/24/2001US6221637 Immunomodulators for treating graft rejection, or nephritis; inhibits signal transduction by t-cells; methyl 2-(carboxymethylsulfinyl)-5,7-dichloro-3,8-dihydroxy-6-methyl-9-oxo-9h -xanthene-1-carboxylate, for example
04/24/2001US6221604 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
04/24/2001CA2031686C 1-bromo-3-chloro-1,2-diaryl-2-propanols, the stereo-selective preparation of erythro-1-bromo-3-chloro-1,2-diaryl-2-propanols and the conversion thereof into azolylmethyloxiranes
04/19/2001WO2001027128A1 C-aryl glucoside sglt2 inhibitors
04/19/2001WO2001027108A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
04/19/2001WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method
04/19/2001WO2001027105A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
04/19/2001WO2001027103A1 Fab i inhibitors
04/19/2001WO2001027091A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
04/19/2001WO2001027089A1 Pyrimidine derivatives
04/19/2001WO2001027087A2 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
04/19/2001WO2001027085A1 Nicotinyl aspartyl ketones as inhibitors of caspase-3
04/19/2001WO2001027084A1 Beta disubstituted metalloprotease inhibitors
04/19/2001WO2001027083A1 Process for the preparation of aryl-pyridinyl compounds
04/19/2001WO2001027081A1 6-position substituted indoline, production and use thereof as a medicament
04/19/2001WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors
04/19/2001WO2001026653A1 V TYPE AND/OR X TYPE sPLA2 INHIBITORS
04/19/2001WO2001026652A1 Fab i inhibitors
04/19/2001WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/19/2001WO2000046198A8 Anti-inflammatory indole derivatives
04/19/2001WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use
04/19/2001DE4244342C2 Benzofuranylimidazolderivate, Verfahren zur Herstellung und therapeutische Präparate, die dieselben enthalten Benzofuranylimidazolderivate, methods of preparation and therapeutic compositions containing the same
04/19/2001DE19949208A1 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
04/19/2001CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method
04/19/2001CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine
04/19/2001CA2387493A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production
04/19/2001CA2386485A1 Beta disubstituted metalloprotease inhibitors
04/19/2001CA2386411A1 Nicotinyl aspartyl ketones as inhibitors of caspase-3
04/19/2001CA2384544A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production
04/19/2001CA2382605A1 Pyrimidine derivatives
04/18/2001EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same
04/18/2001EP1091958A1 Salts of paroxetine
04/18/2001EP1091957A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
04/18/2001EP1091956A1 Muscarinic antagonists
04/18/2001EP1091955A1 Quinolones as serine protease inhibitors
04/18/2001EP1091949A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
04/18/2001EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/18/2001EP1091941A1 Novel benzimidazoles as corticotropin release factor antagonists
04/18/2001EP1091741A1 Azepine derivatives having effects on serotonin related systems
04/18/2001EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections
04/18/2001CN1291984A Glycine transport inhibitors
04/18/2001CN1291977A Amino anthracyclinone derivatives and their use in treatment of amyloidosis
04/18/2001CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors
04/18/2001CN1291653A Piperidine derivative, its preparation method and application
04/18/2001CN1291610A Triazole derivative possessing anti-fungus activity
04/18/2001CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system
04/18/2001CN1064685C Tetrahydrofuran antifungals
04/17/2001US6218549 Bicyclic aminoimidazoles
04/17/2001US6218547 1-phenyl-benzimidazole compounds and their use as GABA-a receptor modulators
04/17/2001US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain.
04/17/2001US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds
04/17/2001US6218431 Substituted biphenyls
04/17/2001US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated
04/17/2001US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal
04/17/2001US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal
04/17/2001US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies
04/17/2001US6218406 As antitumor and antileukemic agents
04/17/2001US6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines
04/17/2001US6218393 Anthranilic acid derivatives as multi drug resistance modulators